Axsome Therapeutics Inc. (NASDAQ: AXSM) kicked off on January 24, 2023, at the price of $69.00, up 1.52% from the previous trading day. During the day, the shares moved up to $70.81 and dropped to $68.33 before settling in for the closing price of $69.75. Over the past 52 weeks, AXSM has traded in a range of $20.63-$82.00.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
While this was happening, its average annual earnings per share was recorded -25.30%. With a float of $35.41 million, this company’s outstanding shares have now reached $41.70 million.
Let’s determine the extent of company efficiency that accounts for 108 employees.
Axsome Therapeutics Inc. (AXSM) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Axsome Therapeutics Inc. is 18.46%, while institutional ownership is 60.40%.
Axsome Therapeutics Inc. (AXSM) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 6/29/2022, the organization reported -$1.06 earnings per share (EPS), higher than consensus estimate (set at -$1.21) by $0.15. This company achieved a return on equity of -201.51. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -25.30% per share during the next fiscal year.
Axsome Therapeutics Inc. (NASDAQ: AXSM) Trading Performance Indicators
Take a look at Axsome Therapeutics Inc.’s (AXSM) current performance indicators. Last quarter, stock had a quick ratio of 4.20. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 114.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.07, a number that is poised to hit -1.13 in the next quarter and is forecasted to reach -3.26 in one year’s time.
Technical Analysis of Axsome Therapeutics Inc. (AXSM)
Looking closely at Axsome Therapeutics Inc. (NASDAQ: AXSM), its last 5-days average volume was 0.88 million, which is a drop from its year-to-date volume of 1.06 million. As of the previous 9 days, the stock’s Stochastic %D was 79.11%. Additionally, its Average True Range was 3.88.
During the past 100 days, Axsome Therapeutics Inc.’s (AXSM) raw stochastic average was set at 74.06%, which indicates a significant decrease from 75.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.10% in the past 14 days, which was lower than the 84.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $69.21, while its 200-day Moving Average is $48.82. However, in the short run, Axsome Therapeutics Inc.’s stock first resistance to watch stands at $71.64. Second resistance stands at $72.46. The third major resistance level sits at $74.12. If the price goes on to break the first support level at $69.16, it is likely to go to the next support level at $67.50. Should the price break the second support level, the third support level stands at $66.68.
Axsome Therapeutics Inc. (NASDAQ: AXSM) Key Stats
The company with the Market Capitalisation of 2.95 billion has total of 43,426K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -130,400 K annual income. Company’s last quarter sales were recorded 16,850 K and last quarter income was -44,820 K.